兒科家庭醫療保健市場規模、佔有率、成長分析，按服務類型、按應用、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

2023 年全球兒科家庭保健市場規模價值為 372 億美元，預計將從 2024 年的 401.4 億美元成長到 2032 年的 737.5 億美元，預測期內（2025-2032 年）的複合年成長率為 7.9%。

兒童因污染導致的慢性疾病（如腦性麻痹、先天性心臟疾病和癌症）的發生率不斷上升，為兒科家庭醫療保健市場創造了巨大的投資機會。在美國，大約有 560 萬兒童需要大量的家庭醫療護理，父母每年花費約 15 億小時，平均每個家庭花費 3,200 美元。維持生命的家庭醫療保健服務減少了患有複雜疾病的嬰幼兒的就診次數，提高了他們的生活品質，同時降低了醫療費用。隨著醫學的進步，早產兒的存活時間更長、能夠更早從新生兒病房出院，對專業居家照護的需求也激增，這刺激了人工呼吸器和霧化器等技術的發展，為患有慢性疾病的嬰兒提供支持。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 客戶和購買標準分析
• Start-Ups分析
• 專利分析

兒科家庭醫療保健市場規模（按服務類型分類）

• 市場概況
• 專業護理服務
• 個人護理協助
• 復健治療服務
  • 物理治療
  • 職能治療
  • 語言治療

兒科家庭保健市場規模（按應用）

• 市場概況
• 慢性病
  • 糖尿病
  • 氣喘
  • 腦性麻痹
• 急性病
  • 呼吸道感染疾病
  • 胃腸道疾病
• 術後護理
• 安寧療護

兒科家庭醫療保健市場規模（按最終用戶分類）

• 市場概況
• 醫院
• 居家照護環境
• 小兒科診所

兒科家庭醫療保健市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• AstraZeneca plc（United Kingdom）
• Pfizer Inc.（United States）
• Sanofi SA（France）
• Boehringer Ingelheim GmbH（Germany）
• Eisai Co., Ltd.（Japan）
• Gilead Sciences, Inc.（United States）
• GlaxoSmithKline plc（United Kingdom）
• Merck & Co., Inc.（United States）
• Novartis AG（Switzerland）
• Johnson & Johnson（United States）
• Eli Lilly and Company（United States）
• Bristol-Myers Squibb Company（United States）
• Amedisys Inc.（United States）
• Maxim Healthcare Services（United States）
• Cardinal Health, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• Team Select Home Care（United States）
• Portea Medical（India）

結論和建議

Global Pediatric Home Healthcare Market size was valued at USD 37.2 billion in 2023 and is poised to grow from USD 40.14 billion in 2024 to USD 73.75 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The growing prevalence of pediatric pollution-related chronic disorders, such as cerebral palsy, congenital heart issues, and cancer, has created significant investment opportunities in the pediatric home healthcare market. In the U.S., approximately 5.6 million children require extensive in-home medical care, leading to an annual parental commitment of around 1.5 billion hours, costing households an average of $3,200 each. Life-sustaining home healthcare services have reduced hospital visits for infants with complex conditions, enhancing their quality of life while also decreasing medical expenses. With medical advancements improving the life expectancy of preterm infants and enabling their earlier discharge from neonatal units, the demand for specialized in-home care has surged, further fueled by technologies such as ventilators and nebulizers that support infants with chronic illnesses.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Home Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Home Healthcare Market Segmental Analysis

Global Pediatric Home Healthcare Market is segmented by Service Type, Application, End-User and region. Based on Service Type, the market is segmented into Skilled Nursing Services, Personal Care Assistance and Rehabilitation Therapy Services. Based on Application, the market is segmented into Chronic Diseases, Acute Illnesses, Post-Surgical Care and Palliative Care. Based on End-User, the market is segmented into Hospitals, Home Care Settings and Pediatric Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pediatric Home Healthcare Market

The global Pediatric Home Healthcare market is driven by several key factors, notably advancements in medical interventions that have improved the life expectancy of premature infants and favorable insurance policies that facilitate access to care. The rise in chronic conditions among children, such as muscular dystrophy, epilepsy, congenital heart diseases, cystic fibrosis, cerebral palsy, and cancer, further fuels market growth. Additionally, the advent of innovative technologies in healthcare systems, particularly in developing nations, is expected to enhance service delivery. However, challenges such as the high cost of services and the need for adequately trained pediatric home healthcare nurses may restrict market expansion.

Restraints in the Global Pediatric Home Healthcare Market

The Global Pediatric Home Healthcare market faces significant constraints, particularly related to costs and workforce training. A recent survey revealed that the typical daily expense for skilled nursing services in private residences amounts to $290, while semi-private facilities charge an average of $255 per day. This discrepancy highlights the financial burden on families seeking quality pediatric care. Additionally, pediatric home care providers encounter difficulties in ensuring that their nursing staff receive adequate training to deliver exceptional care tailored to children with special needs. These factors pose challenges that can hinder the growth and accessibility of pediatric home healthcare services.

Market Trends of the Global Pediatric Home Healthcare Market

The Global Pediatric Home Healthcare market is poised for significant growth as the aftermath of the COVID-19 pandemic amplifies the demand for accessible and affordable healthcare solutions. Families increasingly favor home care services as safe alternatives to traditional hospital visits, motivated by safety concerns and cost-effectiveness. The rising prevalence of chronic conditions among children further accelerates this trend, necessitating continuous medical attention in a familiar environment. Additionally, the limited threat posed by informal care and expensive healthcare facilities ensures a favorable market landscape, positioning pediatric home healthcare as a reliable solution in the evolving healthcare ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Startup Analysis
• Patent Analysis

Global Pediatric Home Healthcare Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Skilled Nursing Services
• Personal Care Assistance
• Rehabilitation Therapy Services
  • Physical Therapy
  • Occupational Therapy
  • Speech Therapy

Global Pediatric Home Healthcare Market Size by Application & CAGR (2025-2032)

• Market Overview
• Chronic Diseases
  • Diabetes
  • Asthma
  • Cerebral Palsy
• Acute Illnesses
  • Respiratory Infections
  • Gastrointestinal Disorders
• Post-Surgical Care
• Palliative Care

Global Pediatric Home Healthcare Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Home Care Settings
• Pediatric Specialty Clinics

Global Pediatric Home Healthcare Market Size & CAGR (2025-2032)

• North America (Service Type, Application, End-User)
  • US
  • Canada
• Europe (Service Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eisai Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amedisys Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maxim Healthcare Services (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Team Select Home Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Portea Medical (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations